Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.0 is now shown, replacing Revision: v3.4.3.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded a new revision entry v3.4.3 and removed the previous revision entry v3.4.2 from the revision history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no study data or essential content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange Detected- The page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now displays a glossary and updates metadata labels to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with minor wording changes such as 'No FEAR Act Data'.SummaryDifference0.2%

- Check66 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no study content or functionality were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.